Skip to main navigation Skip to search Skip to main content

Human Alpha1-Antitrypsin Therapy Synergizes with Temporary T Cell Depletion: Modified Repopulating T Cell Profile in Concordant and Discordant Xenoimmune Models

  • Boris Baranovski
  • , David E Ochayon
  • , Peleg Rider
  • , Omer Nisim
  • , Ronen Schuster
  • , Eli C Lewis

Research output: Contribution to journal › Meeting Abstract

Abstract

Introduction: T cells, primarily CD4+ cells, play a significant role in xenograft rejection. While temporary T cell depletion alone prolongs islet xenograft survival in mice, repopulating T cells acquire a profile that fails to achieve xenograft tolerance. Human α1-antitrypsin (AAT) is an anti-inflammatory and immunomodulatory molecule that allows undeterred purified T cell responses, resulting in, unlike classic immunosuppression, expansion of regulatory T cells (Tregs). Alone, AAT promotes islet allograft survival and fails to extend islet xenograft survival. In combination with temporary T cell depletion, AAT significantly promotes rat-to-mouse islet xenograft survival. The mechanism behind this synergy is unknown.
Original languageEnglish
Pages (from-to)O.2.5
JournalXenotransplantation
Volume24
Issue number5
DOIs
StatePublished - Sep 2017
Event14th Congress of the International Xenotransplantation Association - Baltimore, United States
Duration: 21 Sep 2017 → 23 Sep 2017

Fingerprint

Dive into the research topics of 'Human Alpha1-Antitrypsin Therapy Synergizes with Temporary T Cell Depletion: Modified Repopulating T Cell Profile in Concordant and Discordant Xenoimmune Models'. Together they form a unique fingerprint.

Cite this